Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens

被引：32

作者：

Thigpen, T

Stuart, G

du Bois, A

Friedlander, M

Fujiwara, K

Guastalla, JP

Kaye, S

Kitchener, H

Kristensen, G

Mannel, R

Meier, W

Miller, B

Poveda, A

Provencher, D

Stehman, F

Vergote, I

机构：

来源：

ANNALS OF ONCOLOGY | 2005年 / 16卷

关键词：

D O I：

10.1093/annonc/mdi962

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：13 / 19

页数：7

共 37 条

[1]

Allen D. G., 1995, European Journal of Gynaecological Oncology, V16, P349

[2]

[Anonymous], GYNECOL ONCOL

[3]

BAAK JPA, 1986, ANAL QUANT CYTOL, V8, P354

[4] A PROSPECTIVE RANDOMIZED COMPARISON OF 6 AND 12 CYCLES OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND CISPLATIN IN ADVANCED EPITHELIAL OVARIAN-CANCER - A DANISH OVARIAN STUDY-GROUP TRIAL (DACOVA) [J].

BERTELSEN, K ;

JAKOBSEN, A ;

STROYER, I ;

NIELSEN, K ;

SANDBERG, E ;

ANDERSEN, JE ;

AHRONS, S ;

NYLAND, M ;

PEDERSEN, PH ;

LARSEN, G ;

RASMUSSEN, P ;

KIAER, H ;

BICHEL, P ;

JACOBSEN, M ;

HOLUND, B .

GYNECOLOGIC ONCOLOGY, 1993, 49 (01) :30-36

[5]

BOLIS G, 1992, P AN M AM SOC CLIN, V11, P225

[6] Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].

Bristow, RE ;

Tomacruz, RS ;

Armstrong, DK ;

Trimble, EL ;

Montz, FJ .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259

[7] Critique of surgical cytoreduction in advanced ovarian cancer [J].

Covens, AL .

GYNECOLOGIC ONCOLOGY, 2000, 78 (03) :269-274

[8]

CRAMER SF, 1987, ARCH PATHOL LAB MED, V111, P819

[9]

Dauplat J, 2000, SEMIN SURG ONCOL, V19, P42, DOI 10.1002/1098-2388(200007/08)19:1<42::AID-SSU7>3.0.CO

[10]

2-M

← 1 2 3 4 →